Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxi Zeng

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nature Protocols|April 7, 2018
Design and assessment of engineered CRISPR-Cpf1 and its use for genome editingBin Li, Chunxi Zeng, Yizhou Dong
View (Beijing, China)|November 12, 2021
Advances of nanomaterials-based strategies for fighting against COVID-19Chunxi Zeng, Xucheng Hou, Margaret Bohmer, et al.
Current Topics in Microbiology and Immunology|June 3, 2020
Formulation and Delivery Technologies for mRNA VaccinesChunxi Zeng, Chengxiang Zhang, Patrick G Walker, et al.
Chemical Biology & Drug Design|September 9, 2015
Identification of Spermidine Binding Site in T-box Riboswitch Antiterminator RNAJia Liu, Chunxi Zeng, Vivian Hogan, et al.
Nature Biomedical Engineering|August 26, 2017
Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiencyBin Li, Weiyu Zhao, Xiao Luo, et al.
Bioconjugate Chemistry|March 3, 2020
Rational Design of Small Molecules to Enhance Genome Editing Efficiency by Selectively Targeting Distinct Functional States of CRISPR-Cas12aWenqing Li, Chun Chan, Chunxi Zeng, et al.
Cell Reports|December 20, 2018
Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome EditingBin Li, Chunxi Zeng, Wenqing Li, et al.
Bioorganic & Medicinal Chemistry|April 22, 2019
Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR)Youxi Zhang, Xinfu Zhang, Chunxi Zeng, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 3, 2020
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In VivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nature Protocols|April 7, 2018
Design and assessment of engineered CRISPR-Cpf1 and its use for genome editingBin Li, Chunxi Zeng, Yizhou Dong
View (Beijing, China)|November 12, 2021
Advances of nanomaterials-based strategies for fighting against COVID-19Chunxi Zeng, Xucheng Hou, Margaret Bohmer, et al.
Current Topics in Microbiology and Immunology|June 3, 2020
Formulation and Delivery Technologies for mRNA VaccinesChunxi Zeng, Chengxiang Zhang, Patrick G Walker, et al.
Chemical Biology & Drug Design|September 9, 2015
Identification of Spermidine Binding Site in T-box Riboswitch Antiterminator RNAJia Liu, Chunxi Zeng, Vivian Hogan, et al.
Nature Biomedical Engineering|August 26, 2017
Engineering CRISPR-Cpf1 crRNAs and mRNAs to maximize genome editing efficiencyBin Li, Weiyu Zhao, Xiao Luo, et al.
Bioconjugate Chemistry|March 3, 2020
Rational Design of Small Molecules to Enhance Genome Editing Efficiency by Selectively Targeting Distinct Functional States of CRISPR-Cas12aWenqing Li, Chun Chan, Chunxi Zeng, et al.
Cell Reports|December 20, 2018
Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome EditingBin Li, Chunxi Zeng, Wenqing Li, et al.
Bioorganic & Medicinal Chemistry|April 22, 2019
Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR)Youxi Zhang, Xinfu Zhang, Chunxi Zeng, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Leveraging mRNAs sequences to express SARS-CoV-2 antigens in vivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 3, 2020
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS-CoV-2 Antigens In VivoChunxi Zeng, Xucheng Hou, Jingyue Yan, et al.
Pageof 3